// App-Quantinova.ai

TCT-511 : Two-year Clinical Results with the Angiolite® Drug-Eluting Stent: The ANCHOR Study.

Researchers

Presenter

  • Rishi Puri

Principal Investigators

  • Manel Sabate

  • Antonio Serra

  • Marti Puigfel Pont

  • Armando Perez de Prado

  • Luis Nombela-Franco

  • Jose de la Torre Hernandez

  • Maria Rosario Ortas-Nadal

  • Andres Iniguez

  • Felipe Fernández-Vázquez

  • Carlos Cuellas-Ramon

  • Nieves Gonzalo

  • Victor Jimenez Diaz

  • Luis Duocastella

  • Maria Molina

  • Marc Amoros

  • Isabel Perez

  • Emilie Pelletier-Beaumont

  • Stephen Nicholls

  • Bruno Garcia

  • Josep Rodes-Cabau

Medical Centers

  • iVascular, Barcelona, Spain

  • University Hospital León, León, Spain

  • Quebec Heart & Lung Institute, Quebec City, QC, Canada

  • Hospital Universitario de Girona Dr Josep Trueta, Girona, Spain

  • Hospital Universitario Miguel Servet, Zaragoza, Spain

  • Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  • South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia

  • Hospital Universitario Marques de Valdecilla, Santander, Spain

  • Hospital Clínico San Carlos, IdISSC, Madrid, Spain

  • Hospital Universitari Vall D'Hebron, Barcelona, Spain

  • Hospital Clínic

  • Hospital Alvaro Cunqueiro, Vigo, Spain

  • University of Barcelona, Barcelona, Spain

  • Quebec Heart and Lung Institute/Laval University, Quebec, Quebec, Canada

  • Hospital Alvaro Cunqueiro, University Hospital of Vigo, Vigo, Spain

Locations

  • Spain

  • Canada

  • Australia

  • Sudan

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved